Nuvation Bio, Inc. (NUVB)
4.49
+0.04
(+0.90%)
USD |
NYSE |
May 01, 16:00
4.50
+0.01
(+0.22%)
After-Hours: 20:00
Nuvation Bio EPS Diluted (Quarterly) : -0.1063 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Biohaven Ltd. | -1.211 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Niagen Bioscience, Inc. | 0.0489 |
| Ocugen, Inc. | -0.0567 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.59M |
| Revenue (Quarterly) | 41.86M |
| Total Expenses (Quarterly) | 78.46M |
| Enterprise Value | 1.244B |
| Gross Profit Margin (Quarterly) | 95.66% |
| Profit Margin (Quarterly) | -87.40% |
| Earnings Yield | -13.36% |
| Normalized Earnings Yield | -13.32 |